Stuart Kolinski is SVP General Counsel and Secret at REGENERON PHARMACEUTICALS INC (REGN). They have made 2 open-market trades across 1 company since 2006, most recently 2010-06-03.
CIK 0001226686
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REGN | 16,329 | $12.9M |
Shares reported on the most recent Form 4, priced at the 2010-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REGN | SELL · 10b5-1 | 2010-02-03 | 2010-02-04 | $27.69 | $150K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2010-01-27 | 2010-01-29 | $27.00 | $118K | -13.6% | -2.9% | -2.9% |
| REGN | SELL | 2008-09-19 | 2008-09-22 | $23.44 | $234K | -13.6% | -2.9% | -2.9% |
| REGN | SELL | 2006-08-17 | 2006-08-18 | $15.00 | $30K | -13.6% | -2.9% | -2.9% |
| REGN | SELL · 10b5-1 | 2006-01-09 | 2006-01-10 | $17.33 | $28K | -13.6% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.